Surgical Treatment of Intraorbital Lesions

Standard

Surgical Treatment of Intraorbital Lesions. / Aftahy, Amir Kaywan; Krauss, Philipp; Barz, Melanie; Wagner, Arthur; Meyer, Bernhard; Negwer, Chiara; Gempt, Jens.

in: WORLD NEUROSURG, Jahrgang 155, 11.2021, S. e805-e813.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Aftahy, AK, Krauss, P, Barz, M, Wagner, A, Meyer, B, Negwer, C & Gempt, J 2021, 'Surgical Treatment of Intraorbital Lesions', WORLD NEUROSURG, Jg. 155, S. e805-e813. https://doi.org/10.1016/j.wneu.2021.09.011

APA

Aftahy, A. K., Krauss, P., Barz, M., Wagner, A., Meyer, B., Negwer, C., & Gempt, J. (2021). Surgical Treatment of Intraorbital Lesions. WORLD NEUROSURG, 155, e805-e813. https://doi.org/10.1016/j.wneu.2021.09.011

Vancouver

Aftahy AK, Krauss P, Barz M, Wagner A, Meyer B, Negwer C et al. Surgical Treatment of Intraorbital Lesions. WORLD NEUROSURG. 2021 Nov;155:e805-e813. https://doi.org/10.1016/j.wneu.2021.09.011

Bibtex

@article{744b126d5f4c4bb589e928cd61eaf25a,
title = "Surgical Treatment of Intraorbital Lesions",
abstract = "BACKGROUND: Resection of pure intraorbital tumors is challenging owing to the nearness of the optic apparatus. The objective of this article was to report our experience with different intraorbital tumors and discuss classic approaches and obstacles.METHODS: A retrospective case series of patients who underwent surgery for intraorbital tumors at a tertiary neurosurgical center between June 2007 and January 2020 was performed.RESULTS: The study included 34 patients (median age 58 years; range, 18-87 years; 55.9% [19/34] female, 44.1% [15/34] male). Preoperative proptosis was observed in 67.6% (23/34); visual impairment, in 52.9% (18/34); diplopia, in 41.2% (14/34); and ptosis, in 38.3% (13/34). Intraconal tumors were found in 58.8% (20/34). The most common lesions were cavernous hemangiomas in 26.5% (9/34) and metastases in 14.7% (5/34). Gross total resection rate was 73.5% (25/34). Planned biopsy was performed in 14.7% (5/34). Median follow-up time was 15.5 months (interquartile range: 0-113 months). Surgical approaches included supraorbital approach (23.5% [8/34]), pterional approach (52.9% [18/34]), lateral orbitotomy (14.7% [5/34]), transnasal approach (5.9% [2/34]), and combined transnasal approach/lateral orbitotomy (2.9% [1/34]). Excluding planned biopsies, gross total resection was achieved in 80.0% (12/15) with pterional approach, 100% (7/7) with supraorbital approach, 80.0% (4/5) with lateral orbitotomy, and 100% (1/1) with transnasal approach/lateral orbitotomy. Complication rate requiring surgical intervention was 11.8% (4/34).CONCLUSIONS: Considering the low operative morbidity and satisfactory functional outcome, gross total resection of intraorbital lesions is feasible. We support use of classic transcranial and transorbital approaches. More invasive and complicated approaches were not needed in our series.",
keywords = "Adolescent, Adult, Aged, Aged, 80 and over, Female, Follow-Up Studies, Hemangioma, Cavernous/diagnostic imaging, Humans, Male, Middle Aged, Neurosurgical Procedures/methods, Orbital Neoplasms/diagnostic imaging, Retrospective Studies, Treatment Outcome, Young Adult",
author = "Aftahy, {Amir Kaywan} and Philipp Krauss and Melanie Barz and Arthur Wagner and Bernhard Meyer and Chiara Negwer and Jens Gempt",
note = "Copyright {\textcopyright} 2021 Elsevier Inc. All rights reserved.",
year = "2021",
month = nov,
doi = "10.1016/j.wneu.2021.09.011",
language = "English",
volume = "155",
pages = "e805--e813",
journal = "WORLD NEUROSURG",
issn = "1878-8750",
publisher = "Elsevier Inc.",

}

RIS

TY - JOUR

T1 - Surgical Treatment of Intraorbital Lesions

AU - Aftahy, Amir Kaywan

AU - Krauss, Philipp

AU - Barz, Melanie

AU - Wagner, Arthur

AU - Meyer, Bernhard

AU - Negwer, Chiara

AU - Gempt, Jens

N1 - Copyright © 2021 Elsevier Inc. All rights reserved.

PY - 2021/11

Y1 - 2021/11

N2 - BACKGROUND: Resection of pure intraorbital tumors is challenging owing to the nearness of the optic apparatus. The objective of this article was to report our experience with different intraorbital tumors and discuss classic approaches and obstacles.METHODS: A retrospective case series of patients who underwent surgery for intraorbital tumors at a tertiary neurosurgical center between June 2007 and January 2020 was performed.RESULTS: The study included 34 patients (median age 58 years; range, 18-87 years; 55.9% [19/34] female, 44.1% [15/34] male). Preoperative proptosis was observed in 67.6% (23/34); visual impairment, in 52.9% (18/34); diplopia, in 41.2% (14/34); and ptosis, in 38.3% (13/34). Intraconal tumors were found in 58.8% (20/34). The most common lesions were cavernous hemangiomas in 26.5% (9/34) and metastases in 14.7% (5/34). Gross total resection rate was 73.5% (25/34). Planned biopsy was performed in 14.7% (5/34). Median follow-up time was 15.5 months (interquartile range: 0-113 months). Surgical approaches included supraorbital approach (23.5% [8/34]), pterional approach (52.9% [18/34]), lateral orbitotomy (14.7% [5/34]), transnasal approach (5.9% [2/34]), and combined transnasal approach/lateral orbitotomy (2.9% [1/34]). Excluding planned biopsies, gross total resection was achieved in 80.0% (12/15) with pterional approach, 100% (7/7) with supraorbital approach, 80.0% (4/5) with lateral orbitotomy, and 100% (1/1) with transnasal approach/lateral orbitotomy. Complication rate requiring surgical intervention was 11.8% (4/34).CONCLUSIONS: Considering the low operative morbidity and satisfactory functional outcome, gross total resection of intraorbital lesions is feasible. We support use of classic transcranial and transorbital approaches. More invasive and complicated approaches were not needed in our series.

AB - BACKGROUND: Resection of pure intraorbital tumors is challenging owing to the nearness of the optic apparatus. The objective of this article was to report our experience with different intraorbital tumors and discuss classic approaches and obstacles.METHODS: A retrospective case series of patients who underwent surgery for intraorbital tumors at a tertiary neurosurgical center between June 2007 and January 2020 was performed.RESULTS: The study included 34 patients (median age 58 years; range, 18-87 years; 55.9% [19/34] female, 44.1% [15/34] male). Preoperative proptosis was observed in 67.6% (23/34); visual impairment, in 52.9% (18/34); diplopia, in 41.2% (14/34); and ptosis, in 38.3% (13/34). Intraconal tumors were found in 58.8% (20/34). The most common lesions were cavernous hemangiomas in 26.5% (9/34) and metastases in 14.7% (5/34). Gross total resection rate was 73.5% (25/34). Planned biopsy was performed in 14.7% (5/34). Median follow-up time was 15.5 months (interquartile range: 0-113 months). Surgical approaches included supraorbital approach (23.5% [8/34]), pterional approach (52.9% [18/34]), lateral orbitotomy (14.7% [5/34]), transnasal approach (5.9% [2/34]), and combined transnasal approach/lateral orbitotomy (2.9% [1/34]). Excluding planned biopsies, gross total resection was achieved in 80.0% (12/15) with pterional approach, 100% (7/7) with supraorbital approach, 80.0% (4/5) with lateral orbitotomy, and 100% (1/1) with transnasal approach/lateral orbitotomy. Complication rate requiring surgical intervention was 11.8% (4/34).CONCLUSIONS: Considering the low operative morbidity and satisfactory functional outcome, gross total resection of intraorbital lesions is feasible. We support use of classic transcranial and transorbital approaches. More invasive and complicated approaches were not needed in our series.

KW - Adolescent

KW - Adult

KW - Aged

KW - Aged, 80 and over

KW - Female

KW - Follow-Up Studies

KW - Hemangioma, Cavernous/diagnostic imaging

KW - Humans

KW - Male

KW - Middle Aged

KW - Neurosurgical Procedures/methods

KW - Orbital Neoplasms/diagnostic imaging

KW - Retrospective Studies

KW - Treatment Outcome

KW - Young Adult

U2 - 10.1016/j.wneu.2021.09.011

DO - 10.1016/j.wneu.2021.09.011

M3 - SCORING: Journal article

C2 - 34509678

VL - 155

SP - e805-e813

JO - WORLD NEUROSURG

JF - WORLD NEUROSURG

SN - 1878-8750

ER -